Yao Y F, Inoue Y, Miyazaki D, Shimomura Y, Ohashi Y, Tano Y
Department of Ophthalmology, Osaka University Medical School, Japan.
Invest Ophthalmol Vis Sci. 1995 Dec;36(13):2623-33.
To determine definitively the epithelial origin of corneal resurfacing and to elucidate the immunologic mechanisms of epithelial rejection in a murine keratoepithelioplasty (KEP) model.
After corneal epithelial removal and peritomy, donor corneal lenticules were grafted around the limbus (KEP procedure). The process of corneal reepithelialization was observed with 0.25% methylene blue staining. The origin of the renewed epithelium was determined by immunofluorescence. Syngeneic corneal lenticules were grafted to BALB/c mice. C3H/He, C57BL/6, BALB.K, DBA/2, and B10.D2 allogeneic corneal lenticules were grafted to BALB/c mice, and A.SW and A.TL allogeneic corneal lenticules were grafted to A.TH mice. Alloepithelial rejection was evaluated on the basis of clinical findings and histologic changes in grafted corneas.
All KEP grafts were reepithelialized entirely at 3 days after surgery. The renewed epithelium proved to be derived from the lenticules in BALB/c eyes receiving C3H/He lenticules. In syngeneic grafts 5 days after KEP, the cornea recovered clarity and smoothness, which persisted to the end of the study. After complete reepithelialization, all allogeneic grafts also experienced a short duration of clear cornea. Then followed four characteristic phases of inflammatory epithelial response: initial phase, acute phase, chronic phase, and rejected phase. Histologic examination confirmed the progress and severity of inflammatory response. The mean onset times of initial phase in assorted grafts with mismatched histocompatibility antigens were: 7.9 +/- 1.8 days for both major and minor disparity grafts, 9.5 +/- 3.8 days for major disparity grafts, 18.2 +/- 5.5 days for major histocompatibility class I disparity grafts, 25.6 +/- 7.2 days for major histocompatibility class II disparity grafts, and 9.2 +/- 2.2 days for multiple minor disparity grafts.
In donor corneal lenticule grafting to host eyes with corneal epithelium removed and conjunctival peritomy, the ocular surface was reepithelialized by lenticule-derived epithelium. Alloepithelial rejection in this model displayed characteristic manifestations and well-defined processes, enabling easy and precise evaluation of onset and intensity of graft rejection. Both major and minor histocompatibility antigens are related to corneal epithelial rejection.
在小鼠角膜上皮移植术(KEP)模型中明确角膜表面重塑的上皮来源,并阐明上皮排斥反应的免疫机制。
去除角膜上皮并进行结膜切开术后,将供体角膜透镜移植到角膜缘周围(KEP手术)。用0.25%亚甲蓝染色观察角膜再上皮化过程。通过免疫荧光确定新生上皮的来源。将同基因角膜透镜移植到BALB/c小鼠。将C3H/He、C57BL/6、BALB.K、DBA/2和B10.D2异体角膜透镜移植到BALB/c小鼠,将A.SW和A.TL异体角膜透镜移植到A.TH小鼠。根据移植角膜的临床表现和组织学变化评估异体上皮排斥反应。
所有KEP移植物在术后3天完全再上皮化。在接受C3H/He透镜的BALB/c眼中,新生上皮证明来源于透镜。在KEP术后5天的同基因移植物中,角膜恢复了透明度和平滑度,并持续到研究结束。完全再上皮化后,所有异体移植物也经历了短暂的角膜透明期。随后是炎症上皮反应的四个特征阶段:初始期、急性期、慢性期和排斥期。组织学检查证实了炎症反应的进展和严重程度。在组织相容性抗原不匹配的各种移植物中,初始期的平均发病时间分别为:主要和次要差异移植物均为7.9±1.8天,主要差异移植物为9.5±3.8天,主要组织相容性I类差异移植物为18.2±5.5天,主要组织相容性II类差异移植物为25.6±7.2天,多个次要差异移植物为9.2±2.2天。
在将供体角膜透镜移植到已去除角膜上皮并进行结膜切开术的宿主眼中时,眼表由透镜来源的上皮再上皮化。该模型中的异体上皮排斥反应表现出特征性表现和明确的过程,便于轻松、精确地评估移植物排斥反应的发病时间和强度。主要和次要组织相容性抗原均与角膜上皮排斥反应有关。